Is This Stock a Screaming Buy: Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX)

Equity Research firms currently have a positive stance on shares of Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX). The majority of analysts covering the equity have a consensus Strong Buy recommendation on the stock, yielding a score of 1.00. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $27.25 on a short term basis.

At the time of writing, the stock was trading at $14.65. This represents a change from the opening price of 0.62%. In terms of performance, year to date, the stock is 29.73%. The monthly stock performance comes in at 2.47%. For the quarter, shares are performing at 44.15%. Weekly performance analysis shows the equity at -0.27%.

In taking a look at technical levels, shares are trading 12.14% away from the 50 day simple moving average and 40.02% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -17.47% away from it’s 52- week high and 142.55% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Dipexium Pharmaceuticals, Inc.’s RSI stands at 54.27. In looking at volatility levels, the shares saw weekly volatility of 7.93% and 8.26% over the past month.

Leave a Comment